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Abstract 
Pharmaceutical care as a philosophy is neither universal nor sustainable. Pharmacist prescribing will be the most unifying and 
transformative innovation in pharmacy practice, globally. Scope expansion supported by prescribing rights for pharmacists will 
impact pharmacy and other professions: community pharmacy will evolve into an independent profession; and pharmacy and 
medicine will merge. Important decisions in pharmacy education and practice policy must be made in view of these future changes. 
 
 
Background 
It is established that pharmacy is a healthcare profession. 
“The mission of pharmaceutical practice is to provide 
medication, healthcare products, professional services and to 
help people and society to make best use of medicines” (FIP, 
2009).   
 
Pharmacy has dramatically evolved, over the last 3 decades, 
from a predominantly product-focus to a patient-oriented 
profession. The advent of pharmaceutical care in 1990 
marked the beginning of this revolution.  
 
“Pharmaceutical care is the responsible provision of drug 
therapy for the purpose of achieving definite outcomes that 
improve a patient’s quality of life”. (Hepler and Strand, 1990) 
 
The definition of pharmaceutical care has itself undergone 
numerous revisions to align it with all aspects of pharmacy 
practice; efforts have been made to contextualize 
pharmaceutical care within the broader context of 
healthcare. 
 
“Pharmaceutical care is a patient-centered, outcomes-
oriented pharmacy practice that requires the pharmacist to 
work in concert with the patient and the patient’s other 
healthcare providers to promote health, prevent 
disease, and to assess, monitor, initiate, and modify 
medication use to assure that drug therapy regimens 
are safe and effective’.” (The Pharmaceutical Society of New 
Zealand)  
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Around the globe, however, the implementation of 
pharmaceutical care in community pharmacy has been less 
than satisfactory.  
 
“Pharmacists should move from behind the counter and start 
serving the public by providing care instead of pills only. There 
is no future in the mere act of dispensing. That activity can 
and will be taken over by the internet, machines, and/or 
hardly trained technicians. The fact that pharmacists have an 
academic training and act as health care professionals puts a 
burden upon them to better serve the community than they 
currently do.” 
(Pharmaceutical care, European developments in concepts, 
implementation, and research: a review 2005)  
 
Many pharmaceutical care initiatives and models have been 
proposed and piloted. One such development is pharmacist 
prescribing which has been developed in different formats in 
the UK, USA and Canada. 
 
“Independent prescribers, or non-medical prescribers (NMPs), 
are in a position to give patients timely access to medicines 
and are ideally placed to optimize and individualize 
treatment. The NMP takes responsibility for the clinical 
assessment of the patient, including establishing a diagnosis 
and prescribing the necessary medicines”. (How to become an 
independent prescriber, Pharmaceutical Journal, 2014.)  “ 
 
Limited pharmacy prescribing in community pharmacy is a 
common practice which has been with us, albeit informally, 
for many years. Legally-mandated pharmacist prescribing in 
community pharmacy, the more recent version of pharmacy 
prescribing, is characterized by unprecedented professional 
autonomy and scope. Given the universal simplicity of 
community pharmacy and the numbers of practitioners in 
this sector; any innovation in community pharmacy, in any 
part of the world, has the potential to revolutionize the 
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profession, the world over. This innovation will change 
pharmacy forever. 
 
The Present 
Pharmaceutical care, is it a sustainable mission? 
Contemporary pharmacy practice seems to suggest that 
pharmaceutical care as an ideology may not be sustainable: 
providing pharmaceutical care, consistently and effectively, is 
a choice (only a small proportion of pharmacists seems 
committed to); there is lack of demonstrable willingness on 
the part of consumers and payers to pay for it; there are too 
many levels and models of practice; and too many 
pharmacists still make fulfilling careers out of pharmaceutical 
trade and traditional non-cognitive technical services. 
Further, the dependence of pharmaceutical care on 
pharmacist collaboration with physicians and other 
professionals limits the autonomy of pharmacy as a 
profession. That would suggest that pharmaceutical care as a 
mission does not support the emancipation of pharmacy; it is, 
therefore, inadequate. As pharmaceutical care is, arguably, a 
transitional phase in the evolution of the profession, the 
pursuit for a greater role and mission for pharmacists in drug 
use matters will continue for many years to come. Prescribing 
by pharmacists is one innovation that is likely to garner 
universal support amongst pharmacists around the globe. It 
however presents its own challenges to the mission of 
pharmacy. Although prescribing by pharmacists has 
historically happened across the pharmacy counter, the 
formalization (consolidation) of this rather routine activity 
has some novelty. Pharmacist prescribing has emerged in 
three different contexts: desire to empower highly trained 
pharmacists to ,promptly, implement their care plans; 
deliberate expansion of the scope of various professionals 
including pharmacists; and task shifting ( sharing) 
arrangements to meet shortfalls in qualified staff  or to 
improve cost-efficiency in service delivery. Pharmacist 
prescribing in these varied contexts cannot be accounted for 
by one ideology; pharmaceutical care does not support 
pharmacist prescribing in all contexts.  
 
Response of the medical profession to the expanded scope of 
pharmacy. 
It is inescapable that all professions in the health sector will 
continue to grow at the expense of medicine; pharmacy is no 
exception. Pharmacy continues to borrow from medicine. 
Nothing is more symbolic of this trend than the phenomenal 
growth of non-medical prescribing. The resultant loss of 
territory may prompt the medical profession to respond, to 
this onslaught, by advocating for higher academic 
qualifications for pharmacists and the allied health 
professions. 
 
In the case of pharmacy, pharmacists might decide to raise 
the entry-qualification to a post-graduate degree. Physicians 
might go further and push proposals to transfer the 
regulation of pharmacy to medical boards or even to make 
pharmacy and pharmaceutical care a specialism within 
medicine; it is possible that could be the rebirth of clinical 
pharmacologists or an expansion of the scope of 
pharmaceutical medicine. This is not far-fetched; Clinical 
Pharmacist Practitioners, working under a physician-
administered protocol are required to register their 
collaborative contract simultaneously with both pharmacy 
and medical boards. Another possible and significant reaction 
would be for physicians and other health professionals to 
encroach on pharmacy; on the areas of traditional pharmacy 
that pharmacists, in their quest for greater ‘patient-
centeredness’ are now abandoning.  
 
Context: Consultation, collaboration, referral and delegation. 
Pharmacists provide consultations (or ‘consults’) to both 
patients and health care providers. Consultations with 
physicians may be initiated by either the pharmacist or the 
physician. The common result of a pharmacist-physician 
consult is information or advice which is given by the 
pharmacist to the physician. The physician uses the 
information to make patient care decisions or to resolve a 
specific problem in the care of the patient. 
 
In medical practice, “referral” means the transfer of 
responsibility for the care of a patient. Referral can be 
upward or downward; it is more frequently upward. To date, 
pharmacists have been pushing for collaboration between 
pharmacy and medicine: contemporary collaboration is a 
compromise between consultation and referral wherein the 
physician allows the pharmacist to make a contribution to the 
care of a patient; it does not allow for transfer of 
responsibility for care, let alone outcomes of that care. In 
terms of contemporary pharmaceutical care, referral to 
pharmacists would demand that the physician be bound to 
implement any intervention initiated or proposed by the 
pharmacist. For physicians to feel comfortable to ‘refer’ 
patients to pharmacists, the latter would have to have a 
substantial part of the knowledge that the former uses. In 
other words, they must be clinicians in the medical sense. 
The alternative to referral is “delegation”. Under delegation, 
the physician would hold the pharmacist accountable for 
work done with the patient. Where the delegation is done 
under protocol, the pharmacist becomes accountable only to 
the patient. 
 
Transition 
Training pharmacists to work as physician-extenders. 
Contemporary pharmacy training aims to produce 
practitioners who would offer their expertise to physicians 
who, by law and practice, make therapeutic decisions.  
There are many opportunities, especially in the developing 
world, for pharmacists to collaborate with other health 
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workers, who, in fact, have a more urgent need of the 
pharmacist’s expertise. These health workers may actually 
‘allow’ pharmacists a greater scope for therapeutic decision-
making. In the developed world, highly trained pharmacists 
have been used as physician extenders-namely as patient 
coaches, adherence counsellors and independent or 
dependent prescribers. One wonders whether schools of 
pharmacy should not restructure their curricula to ensure all 
pharmacists enter the profession as physician-extenders. 
 This means: (1) including in the pharmacy curriculum, 
substantial components of the training curricula for 
physicians, nurse practitioners and physician assistants and 
(2) admitting to schools of pharmacy individuals who are 
already qualified as physicians or non-physician clinicians. 
There is, unfortunately, a down-side to this: by positioning 
ourselves as physician-extenders we lose the important 
platform of physician collaborator- this would undermine the 
stature and autonomy of the profession; it would be a major 
set-back for pharmacy.  
 
The Future 
 Future models of clinical pharmacy practice 
The role of clinical pharmacists will change: pharmaceutical 
care will move more upstream to joint-prescribing or 
delegated prescribing. Under joint-prescribing, the traditional 
prescriber and the pharmacist will jointly attend to clients in 
the consultation room, jointly making prescribing decisions; 
in delegated prescribing the traditional clinician will 
undertake clinical assessment of the patient and hand-over 
the patient to the pharmacist who will prescribe the drug 
treatment and plan further care of the patient; just like 
physiotherapy, laboratory testing and medical imaging, drug 
prescribing could be outsourced. Joint-prescribing and 
delegated prescribing would represent a better form of 
‘collaboration’; it would represent a rational division of labor. 
The challenges posed by this ‘arrangement’ include the risk of 
fragmenting care and ‘patient overload’. 
 
Pharmacist prescribing  
The formal legitimation of pharmacist prescribing, by means 
of statute or policy decree, will have important unintended 
effects within and outside the pharmacy profession. Both 
dependent and independent pharmacist prescribing, permits 
pharmacists to put into immediate effect their care plans and 
interventions. Prescribing enables pharmacists to promptly 
deliver more comprehensive care and assume ‘full’ 
responsibility for the outcomes. It renders the pharmacist 
visible to the patient and makes his care ‘tangible, thereby 
elevating the status of the pharmacist from a distant adviser 
(observer?) to a care provider. It reinforces the patient-
pharmacist relationship. 
 
How will pharmacist prescribing impact pharmacy and 
pharmaceutical care in the developed world? 
Autonomy is important for all professions. The right to 
prescribe is, arguably, the last frontier in the struggle (of 
pharmacy and other professions) for emancipation from 
medicine. It is the apex of clinical pharmacy practice. Policy 
makers, responding to pressure from consumers and payers, 
will continue to support pharmacist prescribing. In the 
interest of patient safety, one will expect policy makers to set 
limits or deconcentrate only certain prescribing needs to 
pharmacists. If pharmacist prescribing leads to more effective 
and efficient use of medicines, then pharmacist prescribing in 
the community will lead to much greater savings. 
 As pharmacist prescribing takes root around the world, 
community pharmacy will become the most influential sector 
of the pharmacy profession; pharmacists will extend their 
prescribing to include nutraceuticals, foods, cosmetics and 
alternative remedies. Given their accessibility, community 
pharmacists will attain unprecedented prominence and will 
rival general practice medicine. 
 
With advancements in telemedicine, medical imaging and 
laboratory testing; the importance of a physical examination 
as we know it today will decline- pharmacy will match 
medicine in professional, social and economic privileges .The 
allure of the autonomy and influence of community 
pharmacists will draw to it the Industrial, Hospital and Clinical 
pharmacists. With time and given its broader scope and new 
status, community pharmacy will, likely, break off from the 
rest of the profession. Meanwhile the role of pharmacists in 
traditional practice will be taken over by technicians, non-
pharmacist pharmaceutical specialists and other health 
professionals. 
 
Compared to the pharmaceutical care process, pharmacist 
prescribing is more mechanical and requires little 
professional motivation and commitment. Independent 
pharmacist prescribing, largely, obviates the need for 
collaboration with another professional; it will render 
pharmaceutical care redundant; pharmacist prescribers will 
gradually become more ‘medical’ in their approach to the 
patient. With time the pharmacist prescriber will lose most of 
his pharmaceutical knowledge and skills in favor of more 
‘relevant’ patient care skills. 
 
Impact of pharmacist prescribing on pharmacy practice in the 
developing world. 
In low-economic development countries (LECs) the priority is, 
currently, for pharmacists to make sufficient amounts of 
drugs available at the right cost and quality. Clinical 
pharmacy, in these countries, is virtually non-existent as 
trained clinical pharmacists work in academia, policy 
development, health system management and traditional 
hospital pharmacy. In the developing world, community-
based pharmacists, pharmacy technicians and other drug 
vendors regularly recommend, initiate and administer drug 
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treatment. Considering the high cost of medical care and the 
scarcity of qualified prescribers, it is conceivable that legal 
reforms to permit pharmacist prescribing will be more than 
welcome in LECs. Further, consumers might push for reforms 
in the training curricula of all health workers to include 
courses in medical prescribing. Over time, we are likely to see 
the community pharmacist transforming into some sort of 
clinician- a medical pharmacist- akin to the historical 
apothecary. 
 
What the academy needs to do in view of the future. 
It will be a while before the merger of pharmacy and 
medicine occurs. During the transition period, we have ample 
opportunity to midwife the change, delay, abort it or simply 
adjust to it. The academy, working with the leadership of the 
profession, can play a leading role in managing the 
transitional developments outlined above. The academy 
needs to respond to the following urgent issues through, 
amongst other things, research, theory development, and 
curriculum reforms and practice modelling: 
 
1. The philosophy of pharmacy 
Pharmaceutical care is inadequate in explaining and 
contextualizing pharmacist prescribing. It is pointless 
to have a philosophy or mission that is not universal 
in application. As the state of a nation’s economic 
advancement influences the development of 
pharmacy practice, pharmacists will need to craft a 
more flexible philosophy that is more inclusive. 
2. Working with non-physician clinicians 
We need to train pharmacists who can work even in 
places that are underserved by physicians. Pharmacy 
graduates must be able to work , as equal partners, 
with such non-physician clinicians(NPCs) as nurse 
practitioners, physician assistants (or clinical officers 
and assistants), optometrists, podiatrists, 
physiotherapists, dieticians and even  alternative 
healers. There are three ways to achieve this: we 
could include the curricula of the allied professions 
in the pharmacy curriculum, train pharmacists 
alongside these other professionals or require 
prospective pharmacy students to be qualified allied 
health professionals. 
3. Place and scope of pharmacist prescribing 
If prescribing will increase access to care and is what 
consumers are willing to pay for, then pharmacists 
must become prescribers. However prescribing must 
not blur the line between pharmacy and other 
professions. There is need to think of innovative 
models of practice that would make this goal 
feasible. 
 
 
4. Professional governance 
If pharmaceutical care is essential to patient 
outcomes, then pharmacists must, of necessity, be 
open to the possibility of merging pharmacy with 
medicine or transferring the control of pharmacy 
practice to medicine. 
5. Fate of pharmaceutical science 
Pharmaceutical care will grow at the expense of the 
traditional practice of pharmacy. Loss of the 
scientific content of pharmacy curricula is a threat to 
the identity and future of the profession. Deliberate 
efforts must be made to preserve the uniqueness 
and specialized knowledge of pharmacy. If the 
definition of pharmaceutical care cannot 
accommodate pharmaceutical roles that are not 
considered patient-facing, then there may be need 
to divorce the latter from pharmacy. As this 
happens, we must put in place measures to preserve 
and grow these valuable technical skills by creating a 
parallel profession. 
6. Immediate implications for pharmacy education 
Clearly certain changes are required to align 
education to new realities in pharmacy practice 
during the transition:  
• Pharmacy education may need to be a post-
graduate qualification. 
• Training schools may need to recruit students 
from amongst allied health professionals. 
• The science content of pharmacy education may 
need to be strengthened and fashioned into a 
parallel profession that will be distinct from 
pharmacy. 
• All pharmacy curricula shall be expected to have 
a strong medical component that will include 
skills in patient assessment, diagnosis and 
prescribing. 
• Pharmacists and other clinicians including 
physicians shall increasingly be trained side by 
side. 
Conclusion 
Pharmacy is in need of a new ideology that is more adaptable 
and inclusive. Pharmacist prescribing is the apex of patient-
oriented pharmacy practice. Prescribing in community 
pharmacy, will have universal uptake and immense public 
support; and will transform the profession in a fundamental 
way, and spawn new drug-related professions. The academy, 
working with the leadership of the profession, must prepare 
to guide these changes, in both the short –term and long-
term. 
 
 
